97 related articles for article (PubMed ID: 27459612)
1. [Aberrant methylation of the promoter regions of the SOX7 and p15INK4b genes and Wnt signaling pathway antagonists in patients with acute myeloid leukemias].
Kostroma II; Gritsaev SV; Sidorova ZY; Tiranova SA; Svitina SP; Drizhun YS; Chubukina ZV; Martynkevich IS; Kapustin SI; Bessmeltsev SS
Ter Arkh; 2016; 88(7):31-36. PubMed ID: 27459612
[TBL] [Abstract][Full Text] [Related]
2. Wnt signaling pathway is epigenetically regulated by methylation of Wnt antagonists in acute myeloid leukemia.
Valencia A; Román-Gómez J; Cervera J; Such E; Barragán E; Bolufer P; Moscardó F; Sanz GF; Sanz MA
Leukemia; 2009 Sep; 23(9):1658-66. PubMed ID: 19387464
[TBL] [Abstract][Full Text] [Related]
3. Promoter hypermethylation of p15INK4B, HIC1, CDH1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early-stage patients.
Aggerholm A; Holm MS; Guldberg P; Olesen LH; Hokland P
Eur J Haematol; 2006 Jan; 76(1):23-32. PubMed ID: 16343268
[TBL] [Abstract][Full Text] [Related]
4. p15 (INK4B) and E-cadherin CpG island methylation is frequent in Egyptian acute myeloid leukemia.
El-Shakankiry NH; Mossallam GI
J Egypt Natl Canc Inst; 2006 Sep; 18(3):227-32. PubMed ID: 17671532
[TBL] [Abstract][Full Text] [Related]
5. Methylation of the CpG island near SOX7 gene promoter is correlated with the poor prognosis of patients with myelodysplastic syndrome.
Fan R; Zhang LY; Wang H; Yang B; Han T; Zhao XL; Wang W; Wang XQ; Lin GW
Tohoku J Exp Med; 2012 Jun; 227(2):119-28. PubMed ID: 22706399
[TBL] [Abstract][Full Text] [Related]
6. Gene-specific and global methylation patterns predict outcome in patients with acute myeloid leukemia.
Deneberg S; Grövdal M; Karimi M; Jansson M; Nahi H; Corbacioglu A; Gaidzik V; Döhner K; Paul C; Ekström TJ; Hellström-Lindberg E; Lehmann S
Leukemia; 2010 May; 24(5):932-41. PubMed ID: 20237504
[TBL] [Abstract][Full Text] [Related]
7. Methylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemia.
Christiansen DH; Andersen MK; Pedersen-Bjergaard J
Leukemia; 2003 Sep; 17(9):1813-9. PubMed ID: 12970781
[TBL] [Abstract][Full Text] [Related]
8. Acute myeloid leukemia is characterized by Wnt pathway inhibitor promoter hypermethylation.
Griffiths EA; Gore SD; Hooker C; McDevitt MA; Karp JE; Smith BD; Mohammad HP; Ye Y; Herman JG; Carraway HE
Leuk Lymphoma; 2010 Sep; 51(9):1711-9. PubMed ID: 20795789
[TBL] [Abstract][Full Text] [Related]
9. Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia.
Galm O; Wilop S; Lüders C; Jost E; Gehbauer G; Herman JG; Osieka R
Ann Hematol; 2005 Dec; 84 Suppl 1():39-46. PubMed ID: 16231140
[TBL] [Abstract][Full Text] [Related]
10. Wnt pathway antagonists, SFRP1, SFRP2, SOX17, and PPP2R2B, are methylated in gliomas and SFRP1 methylation predicts shorter survival.
Majchrzak-Celińska A; Słocińska M; Barciszewska AM; Nowak S; Baer-Dubowska W
J Appl Genet; 2016 May; 57(2):189-97. PubMed ID: 26337424
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic inactivation of INK4/CDK/RB cell cycle pathway in acute leukemias.
Chim CS; Wong AS; Kwong YL
Ann Hematol; 2003 Dec; 82(12):738-42. PubMed ID: 14513284
[TBL] [Abstract][Full Text] [Related]
12. Zebularine inhibits human acute myeloid leukemia cell growth in vitro in association with p15INK4B demethylation and reexpression.
Scott SA; Lakshimikuttysamma A; Sheridan DP; Sanche SE; Geyer CR; DeCoteau JF
Exp Hematol; 2007 Feb; 35(2):263-73. PubMed ID: 17258075
[TBL] [Abstract][Full Text] [Related]
13. Suppression of SOX7 by DNA methylation and its tumor suppressor function in acute myeloid leukemia.
Man CH; Fung TK; Wan H; Cher CY; Fan A; Ng N; Ho C; Wan TS; Tanaka T; So CW; Kwong YL; Leung AY
Blood; 2015 Jun; 125(25):3928-36. PubMed ID: 25940713
[TBL] [Abstract][Full Text] [Related]
14. Aberrant methylation of CCAAT/enhancer binding protein zeta promoter in acute myeloid leukemia.
Yao DM; Qian J; Lin J; Wang YL; Chen Q; Qian Z; Li Y; Wang CZ; Yang J
Leuk Res; 2011 Jul; 35(7):957-60. PubMed ID: 21106240
[TBL] [Abstract][Full Text] [Related]
15. An integrated approach of gene expression and DNA-methylation profiles of WNT signaling genes uncovers novel prognostic markers in acute myeloid leukemia.
Taskesen E; Staal FJ; Reinders MJ
BMC Bioinformatics; 2015; 16 Suppl 4(Suppl 4):S4. PubMed ID: 25734857
[TBL] [Abstract][Full Text] [Related]
16. Methylation of p15 and p16 genes in adult acute leukemia: lack of prognostic significance.
Chim CS; Tam CY; Liang R; Kwong YL
Cancer; 2001 Jun; 91(12):2222-9. PubMed ID: 11413509
[TBL] [Abstract][Full Text] [Related]
17. Promoter DNA methylation and expression levels of HOXA4, HOXA5 and MEIS1 in acute myeloid leukemia.
Musialik E; Bujko M; Kober P; Grygorowicz MA; Libura M; Przestrzelska M; Juszczyński P; Borg K; Florek I; Jakóbczyk M; Siedlecki JA
Mol Med Rep; 2015 May; 11(5):3948-54. PubMed ID: 25585874
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic regulation of the non-canonical Wnt pathway in acute myeloid leukemia.
Martín V; Valencia A; Agirre X; Cervera J; San Jose-Eneriz E; Vilas-Zornoza A; Rodriguez-Otero P; Sanz MA; Herrera C; Torres A; Prosper F; Román-Gómez J
Cancer Sci; 2010 Feb; 101(2):425-32. PubMed ID: 19874313
[TBL] [Abstract][Full Text] [Related]
19. Frequent hypermethylation of WNT pathway genes in laryngeal squamous cell carcinomas.
Paluszczak J; Hemmerling D; Kostrzewska-Poczekaj M; Jarmuż-Szymczak M; Grenman R; Wierzbicka M; Baer-Dubowska W
J Oral Pathol Med; 2014 Oct; 43(9):652-7. PubMed ID: 24762262
[TBL] [Abstract][Full Text] [Related]
20. Complete cytogenetic remission after decitabine treatment in a patient with secondary AML harbouring high p15INK4b gene methylation and high global DNA methylation.
Lehmann U; Dobbelstein C; Fenner M; Römermann D; Hasemeier B; Metzig K; Steinemann D; Büsche G; Krauter J; Ganser A; Kreipe H
Ann Hematol; 2009 Mar; 88(3):275-7. PubMed ID: 18704418
[No Abstract] [Full Text] [Related]
[Next] [New Search]
